SARS‐CoV‐2 infection negatively impacts on the quality of embryos by delaying early embryonic development

Abstract

AbstractBackgroundThe COVID‐19 pandemic is an unprecedented health crisis that has affected in vitro fertilization practices globally. Previous studies have shown that SARS‐CoV‐2 impacts the quality of embryos by inducing an immunological response in infertile patients. In this study, the early embryonic development of SARS‐CoV‐2‐infected infertile patients was investigated.MethodsSixty‐five SARS‐CoV‐2 infected infertile patients and 258 controls were involved in this study. The major outcome parameters for the cycle were analyzed, including the number of oocytes, maturation oocytes, available embryos per cycle, and embryo morpho kinetic characteristics.ResultsFrom SARS‐CoV‐2 infection until oocyte retrieval, it took an average of 6.63 days. The results revealed that the number of oocytes and high‐quality embryos on day 3 dramatically reduced in SARS‐CoV‐2‐infected infertile patients. SARS‐CoV‐2 was detected in the follicular fluid of three infertile patients. SARS‐CoV‐2 infection had negatively impacted the number of oocytes in multivariate linear regression models. The early embryonic development in the SARS‐CoV‐2 infection group had a noticeable delay from the six‐cell stage to blastocyst stage.ConclusionsSARS‐CoV‐2 infection reduced the number of oocytes and high‐quality embryos on day 3. It delays the early embryonic development from the six‐cell stage to blastocyst stage and has a negative impact on the quality of embryos.